Go to the blog The Basque company blog

Receive daily information of interest to your company

News 17 June, 2019 Entrepreneurship Innovation R&D Bind 4.0 Bio salud UP Euskadi

VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office

LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells.

LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells.

 

VIVEbiotech, a company specialized in the production of lentiviral vectors for their use in gene therapy, has received notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office.

 

LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells. This novel mechanism of action provides advantages relative to safety and efficiency with respect to the vectors currently in use.

 

When its development phase ends, the advantages of LENTISOMA will position it as one of the vectors of choice for the gene therapies that require it.

 

Therefore, it is very important that LENTISOMA is correctly protected from the Intellectual Property point of view in the United States, bearing in mind that it is the most powerful country in the development of gene therapies.

 

This concession is consistent with the growing number of manufacturing projects that VIVEbiotech is developing in the US market (6 projects currently).

 

Related news

REBEL TICKETS plataforma 24 October, 2023 Entrepreneurship
REBEL TICKETS resale platform, now available on your cell phone
Read more
Wake Up Euskadi 28 October, 2022 Entrepreneurship
Wake up! Resumen de noticias emprendedoras en la Red
Read more
Wake UpEuskadi 10 June, 2022 Entrepreneurship
Wake up! Resumen de noticias emprendedoras en la Red
Read more
1 November, 2021 Entrepreneurship
‘Syngoi Technologies’: Columbus VP creates a new company in Bizkaia for synthetic DNA production
Read more
12 November, 2020 Digitalisation
Meet the 72 Industry 4.0 Startups most valued by the BIND 4.0 Partner Companies and the Finalists for the 5th Edition of the Program
Read more
Go to the blog

Latest news about new subsidies

For SMEs, for diversifying markets, internships abroad, international tenders, non-reimbursable subsidies to consolidate exports, subsidies for deployments or specific training in internationalisation.

You’re interested, right?
// Specialized Channels

Follow us. Specialized channels
and daily news